CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 40 filers reported holding CTI BIOPHARMA CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $28,000 | -72.3% | 6,669 | -60.0% | 0.00% | – |
| Q4 2022 | $101,000 | +320.8% | 16,685 | +295.9% | 0.00% | – |
| Q3 2022 | $24,000 | +700.0% | 4,214 | +644.5% | 0.00% | – |
| Q2 2022 | $3,000 | – | 566 | +1216.3% | 0.00% | – |
| Q1 2022 | $0 | – | 43 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 43 | -6.5% | 0.00% | – |
| Q3 2021 | $0 | – | 46 | +7.0% | 0.00% | – |
| Q2 2021 | $0 | – | 43 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 43 | -80.9% | 0.00% | – |
| Q4 2020 | $1,000 | – | 225 | +3.2% | 0.00% | – |
| Q3 2020 | $0 | – | 218 | +407.0% | 0.00% | – |
| Q2 2020 | $0 | – | 43 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 43 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 43 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 43 | -95.8% | 0.00% | – |
| Q3 2018 | $2,000 | +100.0% | 1,024 | +894.2% | 0.00% | – |
| Q2 2018 | $1,000 | – | 103 | +157.5% | 0.00% | – |
| Q4 2017 | $0 | – | 40 | +122.2% | 0.00% | – |
| Q3 2017 | $0 | – | 18 | +100.0% | 0.00% | – |
| Q1 2017 | $0 | – | 9 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,684,404 | $21,876,000 | 9.07% |
| Lion Point Capital, LP | 5,489,546 | $25,636,000 | 5.95% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2,250,000 | $10,508,000 | 4.35% |
| Bleichroeder LP | 3,859,707 | $18,025,000 | 3.20% |
| NEA Management Company, LLC | 7,140,450 | $99,804,000 | 2.88% |
| BVF INC/IL | 8,929,690 | $41,702,000 | 1.67% |
| Ghost Tree Capital, LLC | 1,300,000 | $6,071,000 | 1.32% |
| EAM Investors, LLC | 1,011,935 | $4,726,000 | 0.88% |
| Knott David M Jr | 556,687 | $2,600,000 | 0.83% |
| Sofinnova Investments, Inc. | 1,952,691 | $9,119,000 | 0.69% |